Skip to content

Effectiveness of Acceptance and Commitment Therapy for patients with insulin-treated diabetes and depressive symptoms: ACT in Diabetes

Effectiveness of Acceptance and Commitment Therapy for patients with insulin-treated diabetes and depressive symptoms: ACT in Diabetes. A replicated randomised single case experimental study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23602
Enrollment
3
Registered
2016-01-26
Start date
2016-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, depression, diabetes self-care behaviour, Acceptance and Commitment Therapy

Interventions

Acceptance and Commitment Therapy (ACT) consisting of eight one-and-a-half hour individual sessions across ten weeks

Sponsors

Zuyderland Medical Centre, Heerlen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. age 18 to 65 years; 2. a diagnosis type 1 or type 2 diabetes mellitus > 6 months ago; 3. suboptimal glycaemic control (HbA1c ≥7.5%/58mmol/mol) 4. intensive insulin treatment (at least 4 dialy administrations regimen; or insulin pump therapy) 5. elevated depressive symptoms (CES-D ≥ 16); 6. motivation for an 8-session psychological intervention focusing on acceptance in chronic illness (based on clinical judgement).

Exclusion criteria

Exclusion criteria: 1. severe psychiatric or somatic comorbidity that hampers participation (e.g. depression with strong suicidal ideation, psychosis, severe cognitive impairment, severe cardiac disease, end-stage cancer); 2. non-fluent in Dutch language, an intellectual disability or lack of verbal abstraction (based on educational level and clinical judgement); 3. earlier treatment based on ACT and/or MBCT; 4. ongoing other psychological treatment; 5. changes in antidepressive medication during the study period; 6. pregnancy.

Design outcomes

Primary

MeasureTime frame
Depression: VAS by PsyMate (App for smartphone) Diabetes self-care behaviour: Self-Care Inventory-revised (SCI-R) (blood glucose regulation)

Secondary

MeasureTime frame
Acceptance: Acceptance and Action Questionnaire- II (AAQ-II) Cognitive fusion: Cognitive Fusion Questionnaire (CFQ13)

Contacts

Public ContactLinda Vondenhoff

Zuyderland Medical Centre, Department of Clinical and Medical Psychology

l.vondenhoff@orbisconcern.nl088-4597837

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)